Market Drivers and Segment Insights in the China Keytruda Industry
The China Keytruda Market is propelled by significant drivers including expansion of clinical trials, increasing healthcare expenditure, and rising awareness of immunotherapy. With the market projected to grow from USD 2,216.6 million in 2025 to USD 5,299 million by 2035 at a CAGR of 9.11%, understanding the key drivers and segment dynamics is essential for stakeholders. The market's expansion...
0 Commentaires 0 Parts 5 Vue 0 Aperçu